Safety risks, including infectious diseases and terrorism, associated with overseas operations
First written in FY2016. 14 of 16 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2022: 38 of 76 companies on the "Worse" side.
38 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「In addition, when personnel stay overseas to conduct business, the Group is taking measures including strengthening safety precautions, diversifying information-gathering channels and alerting travelers and expatriate personnel to potential risks.」
Continues to describe measures for addressing safety risks associated with infectious diseases, terrorism and other events related to overseas operations. - FY2023RestatedAnnual report
「In addition, when personnel stay overseas to conduct business, the Group is taking measures including strengthening safety precautions, diversifying information-gathering channels and alerting travelers and expatriate personnel to potential risks.」
Continues to describe measures for addressing safety risks associated with infectious diseases, terrorism and other events related to overseas operations. - FY2023-Q3RestatedAnnual report
「During the cumulative nine-month period, there were no new business or other risks. In addition, there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
States that there have been no material changes regarding existing risks, including safety risks associated with infectious diseases, terrorism and other events related to overseas operations. - FY2022-Q1RestatedAnnual report
「No new business or other risks arose during the cumulative first quarter of the current fiscal year. There were also no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
States that there have been no material changes regarding existing risks, including safety risks associated with infectious diseases, terrorism and other events related to overseas operations. - FY2021-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
States that there have been no material changes regarding existing risks, including safety risks associated with infectious diseases, terrorism and other events related to overseas operations. - FY2019RestatedAnnual report
「In addition, when personnel stay overseas to conduct business, the Group is taking measures including strengthening safety precautions, diversifying information-gathering channels and alerting travelers to potential risks.」
Continues to describe safety precautions, information gathering and alerts as responses to safety risks associated with infectious diseases, terrorism and other events related to overseas operations. - FY2019-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
States that there have been no new developments or material changes regarding existing risks, including safety risks associated with infectious diseases, terrorism and other events related to overseas operations. - FY2019-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
States that there have been no new developments or material changes regarding existing risks, including safety risks associated with infectious diseases, terrorism and other events related to overseas operations. - FY2019-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
States that there have been no new developments or material changes regarding existing risks, including safety risks associated with infectious diseases, terrorism and other events related to overseas operations. - FY2018-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
States that there have been no new developments or material changes regarding existing risks, including safety risks associated with infectious diseases, terrorism and other events related to overseas operations. - FY2018-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
States that there have been no new developments or material changes regarding existing risks, including safety risks associated with infectious diseases, terrorism and other events related to overseas operations. - FY2017ReframedAnnual report
「In addition, when personnel stay in emerging markets to conduct business, the Group is taking measures including strengthening safety precautions, diversifying information-gathering channels and alerting travelers to potential risks.」
The description has been recast from a list of specific risks such as infectious diseases and terrorism associated with overseas operations to a focus on measures for overseas operations in emerging markets, including safety precautions, information gathering and alerts. - FY2017-Q3RestatedAnnual report
「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The comprehensive risk disclosure regarding safety risks associated with infectious diseases, terrorism and other events related to overseas operations continues to state that there have been no material changes. - FY2017-Q2RestatedAnnual report
「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
The comprehensive risk disclosure regarding safety risks associated with infectious diseases, terrorism and other events related to overseas operations continues to state that there have been no material changes. - FY2017-Q1RestatedAnnual report
「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」
Although the individual risks have not been restated, it is expressly stated that no new risks have arisen and that there have been no material changes to the risks described in the previous fiscal year. - FY2016First statedAnnual report
「In recent years, there have been more cases of personnel staying overseas, particularly in emerging markets, to conduct business, creating the possibility that Company personnel could become involved in infectious diseases, terrorism or other incidents.」
Describes the risk of becoming involved in infectious diseases, terrorism and other incidents as overseas operations increase, particularly in emerging markets, and refers to responses including safety measures and information gathering.